Coherus BioSciences
CHRS
$2.07
Share price
1.47%
Change (1 day)
-71.37%
Change (1 year)
Categories
P/S ratio for Coherus BioSciences (CHRS)
P/S ratio as of April 2024 (TTM): 0.9001
According to Coherus BioSciences 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0.900063. At the end of 2023 the company had a P/S ratio of 1.44.
P/S ratio history for Coherus BioSciences from 2014 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 1.44 | -50.61% |
| 2022 | 2.92 | -22.22% |
| 2021 | 3.75 | 42.61% |
| 2020 | 2.63 | -26.04% |
| 2019 | 3.56 | |
| 2018 | N/A | -100% |
| 2017 | 332 | 5037.79% |
| 2016 | 6.46 | -78.32% |
| 2015 | 29.8 | 70.85% |
| 2014 | 17.4 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 Amgen AMGN | 5.14 | 470.73% | 🇺🇸 USA |
 Repligen
RGEN | 14.6 | 1,517.86% | 🇺🇸 USA |
 Acorda Therapeutics
ACOR | 0.0070 | -99.22% | 🇺🇸 USA |
 Arena Pharmaceuticals
ARNA | N/A | N/A | 🇺🇸 USA |